N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide
C32H38N2O2 — CID 122183518
Data last refreshed: (MolForge compound catalog, from PubChem)
About N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide
N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide (PubChem CID 122183518) has the molecular formula C32H38N2O2 and a molecular weight of 482.67 g/mol. Its IUPAC name is N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide.
Molecular Properties
| Compound Name | N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide |
|---|---|
| PubChem CID | 122183518 |
| Molecular Formula | C32H38N2O2 |
| Molecular Weight | 482.67 g/mol |
| Exact Mass | 482.29 |
| IUPAC Name | N,N-dihexyl-2-(2-naphthalen-2-yl-1H-indol-3-yl)-2-oxoacetamide |
| SMILES | CCCCCCN(CCCCCC)C(=O)C(=O)c1c(-c2ccc3ccccc3c2)[nH]c2ccccc12 |
| InChI | InChI=1S/C32H38N2O2/c1-3-5-7-13-21-34(22-14-8-6-4-2)32(36)31(35)29-27-17-11-12-18-28(27)33-30(29)26-20-19-24-15-9-10-16-25(24)23-26/h9-12,15-20,23,33H,3-8,13-14,21-22H2,1-2H3 |
| InChIKey | JRVWNMBDNLIHGB-UHFFFAOYSA-N |
| XLogP | 8.16 |
| TPSA | 53.17 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 482.67 |
| LogP ≤ 5 | 8.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'diketo_group', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122183518 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.